PharmAla Biotech Holdings, Inc.’s (MDMA) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting PharmAla Biotech Holdings, Inc. is a Buy.

PharmAla Biotech Holdings, Inc.’s (MDMA) 20-Day exponential moving average is 0.20, while PharmAla Biotech Holdings, Inc.’s (MDMA) share price is C$0.19, making it a Sell.

PharmAla Biotech Holdings, Inc.’s (MDMA) 50-Day exponential moving average is 0.20, while PharmAla Biotech Holdings, Inc.’s (MDMA) share price is C$0.19, making it a Sell.

PharmAla Biotech Holdings, Inc. (MDMA) Pivot Points

May 18, 2024, 02:50 PM

Classic

0.17

0.18

0.19

0.20

Fibonacci

0.18

0.19

0.20

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

PharmAla Biotech Holdings, Inc. (MDMA) Moving Averages

May 18, 2024, 02:50 PM

MA5

0.19Sell

0.19Buy

MA10

0.19Sell

MA20

0.20Sell

MA50

0.19Sell

0.20Sell

MA100

0.20Sell

0.19Sell

MA200

0.18Buy

0.20Sell

PharmAla Biotech Holdings, Inc.’s (MDMA) 10-Day exponential moving average is 0.19, while PharmAla Biotech Holdings, Inc.’s (MDMA) share price is C$0.19, making it a Sell.

PharmAla Biotech Holdings, Inc.’s (MDMA) 100-Day exponential moving average is 0.19, while PharmAla Biotech Holdings, Inc.’s (MDMA) share price is C$0.19, making it a Sell.

PharmAla Biotech Holdings, Inc.’s (MDMA) stock price is C$0.19 and PharmAla Biotech Holdings, Inc.’s (MDMA) 50-day simple moving average is 0.19, creating a Sell signal.

PharmAla Biotech Holdings, Inc.’s (MDMA) stock price is C$0.19 and PharmAla Biotech Holdings, Inc.’s (MDMA) 100-day simple moving average is 0.20, creating a Sell signal.

PharmAla Biotech Holdings, Inc.’s (MDMA) stock price is C$0.19 and PharmAla Biotech Holdings, Inc.’s (MDMA) 200-day simple moving average is 0.18, creating a Buy signal.

PharmAla Biotech Holdings, Inc. (MDMA) Technical Indicators

May 18, 2024, 02:50 PM

RSI (14)

47.20

Neutral

STOCH (9,6)

4.76

Buy

STOCHRSI (14)

3.33

Buy

MACD (12,26)

>-0.01

Buy

ADX (14)

28.60

Neutral

Williams %R

-90.00

Buy

CCI (14)

-82.40

Neutral

ATR (14)

0.02

Ultimate Oscillator

40.79

Neutral

ROC

-5.00

Sell

PharmAla Biotech Holdings, Inc.’s (MDMA) Relative Strength Index (RSI) is 47.20, creating a Neutral signal.

PharmAla Biotech Holdings, Inc.’s (MDMA) Trend Strength Indicator (ADX) is 28.60, creating a Neutral signal.

PharmAla Biotech Holdings, Inc.’s (MDMA) Commodity Channel Index (CCI) is -82.40, creating a Neutral signal.

PharmAla Biotech Holdings, Inc.’s (MDMA) Price Rate of Change (ROC) is -5.00, creating a Sell signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is MDMA a Buy, Hold, or Sell?

Based on MDMA’s technical indicators, MDMA is a Sell.

What is MDMA’s RSI (14)?

MDMA’s RSI (14) is 47.20, which suggests MDMA is a Neutral.

What is MDMA’s MACD?

MDMA’s MACD is >-0.01, which suggests MDMA is a Buy.

What is MDMA’s 5-day moving average?

MDMA’s 5-day moving average is 0.19, which suggests MDMA is a Sell.

What is MDMA’s 20-day moving average?

MDMA 20-day moving average is 0.20, which suggests MDMA is a Sell.

What is MDMA’s 50-day moving average?

MDMA’s 50-day moving average is 0.19, which suggests MDMA is a Sell.

What is MDMA’s 200-day moving average?

MDMA’s 200-day moving average is 0.18, which suggests MDMA is a Buy.

What is MDMA’s Williams % R (14)?

MDMA’s Williams % R (14) is -90.00, which suggests MDMA is a Buy.

What is MDMA’s CCI (14)?

MDMA’s CCI (14) is -82.40, which suggests MDMA is a Neutral.

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing